Table 2.

Multivariate Regression Model Results for Logarithm of Quarterly Detailing and Total Promotion Expenditures

	Detailing			Total Promotion
Variable	Coefficient	Standard Error	P-values	Coefficient	Standard Error	P-values
Prozac
Own generic entry	−1.96	0.25	0.004	−2.93	0.14	<0.001
Prozac Weekly entry	−0.63	0.24	0.08	−0.11	0.16	0.55
Constant	9.78	0.05	<0.001	11.00	0.02	<0.001
Paxil
Own generic entry	−0.48	0.30	0.21	−1.63	0.46	0.04
Fluoxetine generic entry	−0.11	0.06	0.17	0.24	0.15	0.21
Paxil CR entry	−1.96	0.38	0.01	−2.31	0.58	0.03
SAD indication	0.12	0.07	0.16	0.40	0.07	0.01
GAD indication	0.31	0.06	0.01	0.10	0.07	0.26
Constant	9.68	0.02	<0.001	10.77	0.02	<0.001
Celexa
Fluoxetine generic entry	0.77	0.41	0.16	0.98	0.48	0.14
Paroxetine generic entry	−1.14	0.72	0.21	−1.86	0.78	0.10
Lexapro entry	−2.20	0.73	0.06	−2.26	0.80	0.07
Constant	9.47	0.43	<0.001	10.03	0.46	<0.001
Zoloft
Fluoxetine generic entry	0.07	0.05	0.22	0.47	0.06	0.01
Paroxetine generic entry	0.10	0.04	0.11	−0.81	0.06	0.001
SAD indication	0.19	0.09	0.12	0.23	0.09	0.08
Constant	9.78	0.02	<0.001	10.93	0.03	<0.001

SAD=social anxiety disorder

GAD=generalized anxiety disorder